Trang chủ › Ung thư phổi › Massachusetts › Boston
Thử nghiệm lâm sàng cho Ung thư phổi tại Boston, MA
62 nghiên cứu cho Ung thư phổi đang tìm kiếm người tham gia tại các cơ sở ở Boston và vùng lân cận (bán kính khoảng 30 dặm). Mở nghiên cứu để xem tiêu chí tham gia và cách liên hệ với đội ngũ nghiên cứu.
Văn bản nghiên cứu chính thức (Tiếng Anh)
Đang tuyển dụng cho một nghiên cứu? Đưa tin của bạn lên đầu trang này — $99 trong 30 ngày →
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Đang tuyểnGiai đoạn 3
- Tufts Medical Center, Boston
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Đang tuyểnGiai đoạn 3
- Boston Medical Center, Boston
- Beth Israel Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Đang tuyểnGiai đoạn 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Distance-Based Exercise to Preserve Function and Prevent Disability
Đang tuyển
- Dana-Farber Cancer Institute, Boston
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Đang tuyểnGiai đoạn 1
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Insitute, Boston
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Đang tuyểnGiai đoạn 3
- Dana-Farber Cancer Institute, Boston
A Study of PHN-012 in Patients With Advanced Solid Tumors
Đang tuyểnGiai đoạn 1
- PHN-012-001 Site, Boston
A Registry for People With Lung Cancer
Đang tuyểnNghiên cứu quan sát
- Massachusetts General Hospital Cancer Center (Data Collection Only), Boston
- Brigham and Women's Hospital (Data Collection Only), Boston
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Đang tuyểnGiai đoạn 2
- Research Site, Boston
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
Đang tuyểnGiai đoạn 2/3
- Dana-Farber Cancer Institute, Boston
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Đang tuyểnGiai đoạn 2/3
- Dana-Farber Cancer Institute, Boston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Đang tuyểnGiai đoạn 1/2
- Dana Farber Cancer Institute, Boston
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Đang tuyểnGiai đoạn 1/2
- Massachusetts General Hospital - Main Campus, Boston
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Đang tuyểnGiai đoạn 1
- Dana-Farber Cancer Institute, Boston
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Đang tuyểnGiai đoạn 1/2
- Dana-Farber Cancer Institute, Boston
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Đang tuyểnGiai đoạn 1
- Dana Farber Cancer Institute, Boston
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
Đang tuyểnGiai đoạn 2
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Đang tuyểnGiai đoạn 1
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Đang tuyểnGiai đoạn 3
- Boston Medical Center, Boston
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Đang tuyểnGiai đoạn 3
- Massachusetts General Hospital, Boston
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Đang tuyểnGiai đoạn 1/2
- Avenzo Therapeutics Recruiting Site, Boston
Investigating Hereditary Risk In Thoracic Cancers (INHERIT)
Đang tuyểnNghiên cứu quan sát
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol B
Đang tuyểnNghiên cứu quan sát
- Massachusetts General Hospital, Boston
Practical Geriatric Assessment in Older Adults With Non-Small Cell Lung Cancer Undergoing Stereotactic Body Radiation Therapy
Đang tuyển
- Brigham and Women's Hospital, Boston
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Đang tuyểnNghiên cứu quan sátChào đón tình nguyện viên khỏe mạnh
- Dana Farber Cancer Institute, Boston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Đang tuyểnGiai đoạn 1/2
- Massachusetts General Hospital Cancer Center, Boston
Preliminary Efficacy of Different Exercise Training During Immunotherapy in Patients With Lung Cancer: The ENHANCE Trial
Đang tuyển
- Dana-Farber Cancer Institute, Boston
Precise Exercise Regimen for Cancer Care (PERCC): A Pilot Study
Đang tuyển
- Dana-Farber Cancer Institute, Boston
Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC
Đang tuyểnGiai đoạn 2
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations
Đang tuyểnChào đón tình nguyện viên khỏe mạnh
- Beth Israel Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
- Massachusetts General Hospital, Boston
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Đang tuyểnGiai đoạn 1/2
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancer
Đang tuyển
- Massachusetts General Hospital, Boston
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
Đang tuyểnGiai đoạn 1
- Massachusetts General Hospital, Boston
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Đang tuyểnGiai đoạn 1/2
- Dana Farber Cancer Institute, Boston
Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
Đang tuyểnNghiên cứu quan sát
- Dana-Farber Cancer Institute, Boston
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Đang tuyểnGiai đoạn 1
- Mass General Brigham Cancer Institute at Massachusetts General Hospital, Boston
Prediction Augmented Screening Initiative
Đang tuyển
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Đang tuyểnGiai đoạn 1
- Research Site, Boston
- Research Site, Boston
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Đang tuyểnGiai đoạn 1
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Đang tuyểnGiai đoạn 1/2
- Massachusetts General Hospital,, Boston
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Đang tuyểnGiai đoạn 1/2
- Dana Farber Cancer Institute, Boston
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
Đang tuyểnGiai đoạn 1/2
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Deep Learning Using Chest X-Rays to Identify High Risk Patients for Lung Cancer Screening CT
Đang tuyển
- Massachusetts General Hospital, Boston
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Đang tuyểnGiai đoạn 1/2
- Massachusetts General Hospital, Boston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Đang tuyểnGiai đoạn 1/2
- Dana Farber Cancer Institute, Boston
Avecure Flexible Microwave Ablation Probe For Lung Nodules
Đang tuyển
- Beth Israel Deaconess Medical Center, Boston
A Digital Health Intervention to Improve Physical Function and Wellness of Lung Cancer Survivors
Đang tuyển
- Massachusetts General Hospital, Boston
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Đang tuyểnGiai đoạn 1/2
- Dana-Farber Cancer Institute, Boston
Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens
Đang tuyểnChào đón tình nguyện viên khỏe mạnh
- Brigham and Womens Hospital, Boston
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
Đang tuyểnChào đón tình nguyện viên khỏe mạnh
- Massachusetts General Hospital (MGH) / Harvard, Boston
Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury
Đang tuyểnGiai đoạn 2
- Massachusetts General Hospital, Boston
Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients
Đang tuyểnGiai đoạn 1Chào đón tình nguyện viên khỏe mạnh
- Massachusetts General Hospital, Boston
Lung Cancer Screening in High-risk Black Individuals
Đang tuyểnChào đón tình nguyện viên khỏe mạnh
- Massachusetts General Hospital Cancer Center, Boston
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Đang tuyển
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Image Guided VATS vs. VATS Resection
Đang tuyển
- Brigham and Women's Hospital, Boston
Stereotactic Magnetic Resonance Guided Radiation Therapy
Đang tuyển
- Brigham & Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
Đang tuyểnNghiên cứu quan sát
- Massachusetts General Hospital, Boston
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Đang tuyểnGiai đoạn 1/2
- Dana Farber Cancer Institute, Boston
Comprehensive Outcomes for After Cancer Health
Đang tuyểnChào đón tình nguyện viên khỏe mạnh
- Dana Farber Cancer Institute, Boston
DNA Analysis of Blood and Tissue from Patients with Lung Cancer
Đang tuyểnNghiên cứu quan sátChào đón tình nguyện viên khỏe mạnh
- Massachusetts General Hospital, Boston
- Harvard School of Public Health, Boston
Molecular and Genetic Analysis of Lung Cancer
Đang tuyểnNghiên cứu quan sátChào đón tình nguyện viên khỏe mạnh
- Massachusetts General Hospital, Boston
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
Đang tuyểnNghiên cứu quan sát
- Boston University Medical Center, Boston
Thử nghiệm cho Ung thư phổi tại các thành phố khác
- Houston, TX78 nghiên cứu
- New York City, NY60 nghiên cứu
- Los Angeles, CA45 nghiên cứu
- Arlington, VA41 nghiên cứu
- Washington, DC41 nghiên cứu
- Chicago, IL41 nghiên cứu
- Baltimore, MD40 nghiên cứu
- Nashville, TN40 nghiên cứu
- St. Louis, MO39 nghiên cứu
- Columbus, OH37 nghiên cứu
- Philadelphia, PA36 nghiên cứu
- Seattle, WA33 nghiên cứu
Các nghiên cứu khác tại Boston
- Ung thư vú112 nghiên cứu
- Ung thư phổi không tế bào nhỏ90 nghiên cứu
- Ung thư (mọi loại)85 nghiên cứu
- Ung thư di căn63 nghiên cứu
- Ung thư đại trực tràng63 nghiên cứu
- Ung thư buồng trứng61 nghiên cứu
- Ung thư tuyến tiền liệt59 nghiên cứu
- Trầm cảm52 nghiên cứu
- Ung thư nội mạc tử cung50 nghiên cứu
- Suy tim44 nghiên cứu
- Bạch cầu tủy cấp44 nghiên cứu
- Ung thư tụy43 nghiên cứu
Nguồn dữ liệu từ ClinicalTrials.gov, cập nhật ngày 6 thg 10, 2026. Mỗi nghiên cứu có tiêu chí riêng; đội ngũ nghiên cứu sẽ quyết định ai đủ điều kiện tham gia.